Hyloris Sets Out Plans To Expand Its Pipeline

Value Added Medicines Company Aims For 14 Commercial Products By 2024

expansion
Hyloris reveals plans to add at least three products to its pipeline in 2021 and commercialize 14 products by 2024 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Earnings

More from Business